0001946593-22-000001.txt : 20221003 0001946593-22-000001.hdr.sgml : 20221003 20221003160908 ACCESSION NUMBER: 0001946593-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221003 DATE AS OF CHANGE: 20221003 EFFECTIVENESS DATE: 20221003 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EnPlusOne Biosciences Inc. CENTRAL INDEX KEY: 0001946593 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-460553 FILM NUMBER: 221287588 BUSINESS ADDRESS: STREET 1: 313 PLEASANT STREET STREET 2: 4W CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 6177446739 MAIL ADDRESS: STREET 1: 313 PLEASANT STREET STREET 2: 4W CITY: WATERTOWN STATE: MA ZIP: 02472 D 1 primary_doc.xml X0708 D LIVE 0001946593 EnPlusOne Biosciences Inc. 313 PLEASANT STREET 4W WATERTOWN MA MASSACHUSETTS 02472 6177446739 DELAWARE None None Corporation true 2022 Daniel Wiegand 313 Pleasant Street 4W Watertown MA MASSACHUSETTS 02472 Executive Officer Director Daniel Ahlstedt 313 Pleasant Street 4W Watertown MA MASSACHUSETTS 02472 Executive Officer Director Daniel Janse 313 Pleasant Street 4W Watertown MA MASSACHUSETTS 02472 Director Andrew Lee 313 Pleasant Street 4W Watertown MA MASSACHUSETTS 02472 Director Steven Kasok 313 Pleasant Street 4W Watertown MA MASSACHUSETTS 02472 Director Biotechnology Decline to Disclose 06b false 2022-08-30 false true false 0 12396705 11896705 500000 The total offering amount and the total amount sold include the conversion of $1,296,705 of outstanding convertible securities. false 6 0 0 0 false EnPlusOne Biosciences Inc. /s/Daniel Wiegand Daniel Wiegand Chief Executive Officer 2022-09-30